OLIG2

Source: Wikipedia, the free encyclopedia.
OLIG2
Identifiers
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo / QuickGO
Ensembl
UniProt
RefSeq (mRNA)

NM_005806

NM_016967

RefSeq (protein)

NP_005797

NP_058663

Location (UCSC)Chr 21: 33.03 – 33.03 MbChr 16: 91.02 – 91.03 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Oligodendrocyte transcription factor (OLIG2) is a basic helix-loop-helix (

bHLH) transcription factor encoded by the OLIG2 gene. The protein is of 329 amino acids in length, 32 kDa in size and contains one basic helix-loop-helix DNA-binding domain.[5] It is one of the three members of the bHLH family. The other two members are OLIG1 and OLIG3. The expression of OLIG2 is mostly restricted in central nervous system, where it acts as both an anti-neurigenic and a neurigenic factor at different stages of development. OLIG2 is well known for determining motor neuron and oligodendrocyte differentiation, as well as its role in sustaining replication in early development. It is mainly involved in diseases such as brain tumor and Down syndrome
.

Function

OLIG2 is mostly expressed in restricted domains of the brain and

embryogenesis, OLIG2 first directs motor neuron fate by establishing a ventral domain of motor neuron progenitors and promoting neuronal differentiation. OLIG2 then switches to promoting the formation of oligodendrocyte precursors and oligodendrocyte differentiation at later stages of development. Apart from functioning as a neurogenic factor in specification and the differentiation of motor neurons and oligodendrocytes, OLIG2 also functions as an anti-neurogenic factor at early time points in pMN progenitors to sustain the cycling progenitor pool. This side of anti-neurogenicity of OLIG2 later plays a bigger role in malignancies like glioma.[6]

The role of phosphorylation has been highlighted recently to account for the multifaceted functions of OLIG2 in differentiation and proliferation. Studies showed that the phosphorylation state of OLIG2 at Ser30 determines the fate of cortical progenitor cells, in which cortical progenitor cells will either differentiate into astrocytes or remain as neuronal progenitors.[7] Phosphorylation at a triple serine motif (Ser10, Ser13 and Ser14) on the other hand was shown to regulate the proliferative function of OLIG2.[8] Another phosphorylation site Ser147 predicted by bioinformatics was found to regulate motor neuron development by regulating the binding between OLIG2 and NGN2.[9] Further, OLIG2 contains a ST box composed of a string of 12 contiguous serine and threonine residues at position Ser77-Ser88. It is believed that phosphorylation at ST box is biologically functional,[10] yet the role of it still remains to be elucidated in vivo.[11]

OLIG2 has also been implicated in bovine horn ontogenesis. It was the only gene in the bovine polled locus to show differential expression between the putative horn bud and the frontal forehead skin.[12]

Clinical Significance

OLIG2 in Cancer

OLIG2 is well recognized for its importance in cancer research, particularly in brain tumors and

mRNA levels of OLIG2 were associated with better overall survival, but this association was completely dependent on IDH mutation status.[14]

In particular, OLIG2 is selectively expressed in a subgroup of glioma cells that are highly tumorigenic,[15] and is shown to be required for proliferation of human glioma cells implanted in the brain of severe combined immunodeficiency (SCID) mice.[16]

Though the molecular mechanism behind this tumorigenesis is not entirely clear, more studies have recently been published pinpointing diverse evidence and potential roles for OLIG2 in glioma progression. It is believed that OLIG2 promotes neural stem cell and progenitor cell proliferation by opposing

RhoA.[21]

Besides glioma, OLIG2 is also involved in leukemogenesis. The Olig2 gene was actually first identified in a study in T-cell

non-small cell lung carcinoma cell lines.[23] It also has been shown that up-regulation of OLIG2 together with LMO1
and Notch1 helps to provide proliferation signals.

OLIG2 in Neural Diseases

OLIG2 is also associated with Down syndrome, as it locates at

single nucleotide polymorphisms (SNPs) associated with these diseases in OLIG2 were identified by genome-wide association work.[25][26]

OLIG2 also plays a functional role in neural repair. Studies showed that the number of OLIG2-expressing cells increased in the lesion after cortical stab-wound injury, supporting the role for OLIG2 in reactive

astrocytes possibly in a transient re-expression manner, but the mechanisms are unclear.[28]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000205927Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000039830Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "OLIG2". Atlas of Genetics and Cytogenetics in Oncology and Hematology.
  6. S2CID 18323261
    .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .
  13. .
  14. ^ .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. .
  21. .
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. .

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This page is based on the copyrighted Wikipedia article: OLIG2. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy